BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:NCR201 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of NCR201\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07896187-1602@assetmemo.bio
DTSTAMP:20261121T005831Z
DTSTART;VALUE=DATE:20281031
DTEND;VALUE=DATE:20281101
SUMMARY:NCR201: Phase 1 readout est. (NCT07896187)
DESCRIPTION:NCR201\, phase 1\, Parkinson's Disease.\nStudy: A Phase 1 Study
  of NCR201 in Parkinson's Disease Patients With Prior DBS\nEstimated prima
 ry completion: October 2028. This is a ClinicalTrials.gov estimate\, not a
  confirmed readout date\, and it can move.\nDrug page: https://assetmemo.b
 io/drug/ncr201#upcoming-events\nRegistry record: https://clinicaltrials.go
 v/study/NCT07896187
URL:https://assetmemo.bio/drug/ncr201#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
